Montréal techbio company selling a no-code SaaS platform for AI-driven disease simulation that combines mechanistic modelling with machine learning over protein networks and multi-omics data to score drug targets.
Canadian innovation builds a brighter tomorrow.
Montréal techbio company selling a no-code SaaS platform for AI-driven disease simulation that combines mechanistic modelling with machine learning over protein networks and multi-omics data to score drug targets.
Federal corporation 1008969-9 (Simmunome Inc.), status Active, with its registered office on boulevard René-Lévesque Est in Montréal. ised-isde.canada.ca
Selected for Merck Digital Sciences Studio's first Canadian cohort in 2025, receiving US$100,000 via the Merck Global Health Innovation Fund and CQDM. simmunome.com
Raised a $2 million pre-seed round led by Theodorus and Fonds d'investissement Eurêka, with BKR Capital, Sandpiper and ACET Capital. simmunome.com
Announced a partnership with Mila in November 2023 to advance AI in drug development. simmunome.com
Products Simmunome publishes on its own site. Each card links to the page it was taken from.
AI disease simulation
Company describes a no-code SaaS platform for AI-driven disease simulations whose foundation model integrates protein networks, multi-omics data and clinical evidence, with BioTarget Scoring, Omic Signatures and data-exploration tools.
Learn moreAnnounced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Sep 18, 2023
Investors: Theodorus, Fonds d'investissement Eurêka, BKR Capital, Sandpiper, ACET Capital
Publicly announced partnerships.
Partnership announced November 2023 to advance AI in drug development.
Member of the studio's first Canadian cohort (2025), receiving US$100,000 via the Merck Global Health Innovation Fund and CQDM.
Sourced from the company's own pages or announcements.
Armstrong Murira
Co-founder and Chief Executive Officer
Terms the company uses about its own work.
Other companies in AI.
Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.
